Dr. Stuart J. Shafer, MD

Dr. Shafer practices at Vero Beach Neurology And Research Institute in Vero Beach, Florida.

Dr. Shafer's NPI, 1003818816, was assigned on August 11, 2005. Dr. Shafer graduated from University of Miami, Miller School of Medicine in 1993. Dr. Shafer holds Florida license ME0072261.

Dr. Shafer's primary practice is Vero Beach Neurology and Research Institute, at 1040 37th Pl Suite 201 Suite 201, Vero Beach, FL 32960-4818. The practice phone is (772) 492-7051.

Dr. Shafer's primary practice is Vero Beach Neurology And Research Institute in Vero Beach, Florida. Dr. Shafer is also affiliated with Cleveland Clinic Indian River Hospital. The medical group on file is Vero Beach Neurology and Research Institute. Dmand AI also links Dr. Shafer to 2 more hospitals, 2 home health agencies and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shafer practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Shafer's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Shafer is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Shafer is licensed in Florida.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor and fibromyalgia and chronic pain among the conditions Dr. Shafer treats.

CMS data shows 92,632 Medicare services from Dr. Shafer across 32 procedure codes in 2024, for 1,524 Medicare patients. Medicare paid $714,967 for them. Every service was in an office.

CMS counts 1,524 Medicare patients who saw Dr. Shafer in 2024. The largest group is 75 to 84, with 726 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shafer's median patient age at 75, with 56% women.

In 2024, Dr. Shafer wrote 7,144 Medicare Part D claims for 1,242 patients. 94% of them were for generic drugs. CMS names the drug for 6,725 of them, across 87 drugs with 11 or more claims each, at $1,907,125 in total drug cost. In 2023, CMS named 5,676 claims across 81 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Shafer for performance year 2024, reported as part of a group. Dr. Shafer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shafer as offering telehealth.

Dmand AI links 2 papers to Dr. Shafer. Dr. Shafer's most frequent co-authors are Suzanne K. Gazda, MD, Fabian H. Rossi, MD and Emmanuelle L. Waubant, MD.

Dmand AI links Dr. Shafer to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Alzheimer Disease, dopamine beta hydroxylase deficiency and Multiple Sclerosis.

CMS Open Payments shows 1,130 general payments to Dr. Shafer from 73 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Mallinckrodt LLC paid the most, $49,064. It also lists 4 research payments totaling $1,977 in 2018.

Dmand AI lists 1 award for Dr. Shafer, most recently CMS Stage 1 EHR in 2014.

Dr. Shafer graduated from University of Miami, Miller School of Medicine in 1993. Dr. Shafer is a member of AAN.

Dr. Shafer is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.